Your browser doesn't support javascript.
loading
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders.
Zhou, Liye; Zeng, Zexian; Egloff, Ann Marie; Zhang, Fan; Guo, Fei; Campbell, Katie M; Du, Peter; Fu, Jingxin; Zolkind, Paul; Ma, Xiaojing; Zhang, Zhe; Zhang, Yi; Wang, Xiaoqing; Gu, Shengqing; Riley, Rachel; Nakahori, Yasutaka; Keegan, Joshua; Haddad, Robert; Schoenfeld, Jonathan D; Griffith, Obi; Manguso, Robert T; Lederer, James A; Liu, X Shirley; Uppaluri, Ravindra.
Afiliación
  • Zhou L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Zeng Z; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Egloff AM; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Zhang F; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Guo F; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Campbell KM; Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Du P; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Fu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Zolkind P; Clinical Translational Research Center, Shanghai Pulmonary Hospital, School of Life Science and Technology, Tongji University, Shanghai, People's Republic of China.
  • Ma X; Department of Otolaryngology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
  • Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Zhang Y; School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, People's Republic of China.
  • Wang X; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Gu S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Riley R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Nakahori Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Keegan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Haddad R; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Schoenfeld JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Griffith O; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Manguso RT; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Lederer JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Liu XS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Uppaluri R; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.
J Immunother Cancer ; 10(1)2022 01.
Article en En | MEDLINE | ID: mdl-35058328
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Inhibidores de Puntos de Control Inmunológico / Neoplasias de Cabeza y Cuello Límite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD8-positivos / Inhibidores de Puntos de Control Inmunológico / Neoplasias de Cabeza y Cuello Límite: Animals / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos